Rafael holdings reports third quarter fiscal 2022 financial results

Newark, n.j., june 14, 2022 (globe newswire) -- rafael holdings, inc. (nyse: rfl), an early-stage novel cancer and immune metabolism therapeutics company, today reported its financial results for the three and nine months ended april 30, 2022. the company is focused on accelerating the development of its novel cancer and immune metabolism pipeline while exploring strategic opportunities to further enhance value.
RFL Ratings Summary
RFL Quant Ranking